Form 4: OS Therapies Director and 10% Owner, Shalom Auerbach, Reports Conversion of Promissory Notes to Common Stock Following IPO

Shalom Auerbach, a director and 10% owner of OS Therapies Inc, reported the conversion of multiple convertible promissory notes into common stock following the company's initial public offering.

Summary

• Shalom Auerbach, a director and 10% owner of OS Therapies Inc, has filed a Form 4 detailing changes in his beneficial ownership.
• The changes are due to the automatic conversion of convertible promissory notes into common stock upon the consummation of the company's initial public offering on August 2, 2024.
• Mr. Auerbach directly received 23,371 shares of common stock from a $25,000 note conversion at $1.31 per share.
• Einodmil LLC, of which Mr. Auerbach is the Principal, received a total of 2,524,560 shares of common stock from the conversion of multiple notes at $2.00 per share.
• The total shares beneficially owned by Mr. Auerbach, including those held indirectly through Einodmil LLC, is 2,547,931.

Sentiment

Score: 7

Explanation: The document reflects a standard process following an IPO, with no negative implications. The conversion of debt to equity is generally a positive sign, but the potential dilution is a neutral factor.

Positives

• The conversion of promissory notes into equity indicates a commitment from a key insider.
• The IPO has triggered the conversion of debt into equity, which can be seen as a positive step for the company's capital structure.

Risks

• The document does not indicate any specific risks, but the conversion of debt to equity could potentially dilute existing shareholders.

Industry Context

This filing is a standard SEC requirement for insiders following a company's IPO and the conversion of debt to equity. It is common for early investors and insiders to hold convertible notes that convert upon an IPO.

Comparison to Industry Standards

• The conversion of promissory notes to equity upon an IPO is a common practice in the venture capital and private equity industry.
• The conversion prices of $1.31 and $2.00 per share are typical for early-stage investments in companies going public.
• The reporting of beneficial ownership changes via Form 4 is a standard regulatory requirement for all publicly traded companies in the US.

Stakeholder Impact

• Existing shareholders may experience some dilution due to the issuance of new shares.
• The conversion of debt to equity strengthens the company's balance sheet.

Key Dates

Keywords

Form 4, Beneficial Ownership, Convertible Promissory Note, Initial Public Offering, Common Stock, OS Therapies, Shalom Auerbach, Einodmil LLC